Skip to content

Itci stock price forecast

HomeVoorhis80109Itci stock price forecast
28.11.2020

26 Feb 2020 On Tuesday, shares of Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) marked ally in the technical patterns of the stock movements showed in stock charts. on the price of ITCI shares, based on the price prediction for ITCI,  View today's stock price, news and analysis for Intra-Cellular Therapies Inc. (ITCI) . Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation and more. Estimate, -0.87, -0.83, -0.80, - 0.81. Current Technical Analysis and interactive chart for $ITCI stock / shares. The stock exhibited some range contraction during this trading session as price Mar 27, Intra-Cellular Therapies (ITCI): Strong Industry, Solid Earnings Estimate  ITCI, Intra-Cellular Therapies - Stock quote performance, technical chart Intra- Cellular Therapies (ITCI): Strong Industry, Solid Earnings Estimate Revisions. Mar-27-20 10:11AM, Intra-Cellular Therapies (ITCI): Strong Industry, Solid Earnings Estimate Revisions Zacks. Mar-23-20 07:30AM, Intra-Cellular Therapies  5 Nov 2012 Here we use historical data to predict the movement of stock price for next day. It is completely mathematically valid. ITCI - Intra-Cellular Therapies Inc Stock quote - CNNMoney.com

View today's stock price, news and analysis for Intra-Cellular Therapies Inc. (ITCI) . Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation and more. Estimate, -0.87, -0.83, -0.80, - 0.81.

Based on 4 analysts offering 12 month price targets for Intra-Cellular Therapies in the last 3 months. The average price target is $46.00 with a high forecast of  See ITCI stock predictions by 9 financial experts and find out if their Intra-Cellular Therapies stock forecast (ITCI) is more bullish in comparison to other stocks in  Intra-Cellular Therapies (ITCI) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well. GlobeNewswire•15   Get the latest Intra-Cellular Therapies Inc. ITCI detailed stock quotes, stock Intra-Cellular Therapies (ITCI): Strong Industry, Solid Earnings Estimate Revisions.

View Intra-Cellular Therapies Inc. ITCI investment & stock information. Get the latest Intra-Cellular Therapies Inc. ITCI detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.

Intra-Cellular Therapies - ITCI - Stock Price & News | The ... Real time Intra-Cellular Therapies (ITCI) stock price quote, stock graph, news & analysis. Real time Intra-Cellular Therapies (ITCI) stock price quote, stock graph, news & analysis. ITCI Intra-Cellular Therapies — Stock Price and Discussion ... Apr 03, 2020 · Securities products and services offered to self-directed investors through ST Invest, LLC. Member FINRA / SIPC.ST Invest is a wholly owned subsidiary of StockTwits, Inc. Investing in securities products involves risk, including possible loss of principal. Please read important legal disclosures.

View today's stock price, news and analysis for Intra-Cellular Therapies Inc. (ITCI) . Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation and more. Estimate, -0.87, -0.83, -0.80, - 0.81.

Analysts Issue Forecasts for Intra-Cellular Therapies Inc ... ITCI has been the topic of several other reports. BTIG Research lowered their target price on shares of Intra-Cellular Therapies from $73.00 to $68.00 and set a “buy” rating on the stock in a ITCI Earnings Date, Forecast and Report (Intra-Cellular ... Intra-Cellular Therapies (NASDAQ:ITCI) Earnings Information Intra-Cellular Therapies last posted its earnings results on March 2nd, 2020. The biopharmaceutical company reported ($0.74) EPS for the quarter, beating the consensus estimate of ($0.81) by $0.07.

SRRA - Sierra Oncology Inc Stock quote - CNNMoney.com

Stock Comparison: Compare Intra-Cellular Therapies Inc ... Mar 13, 2020 · Online Stock Comparison - Compare Intra-Cellular Therapies Inc. (ITCI) to four other stocks with NASDAQ.com's stock comparison tool.